ArticleClinical pharmacokinetics2022

The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition.

Amina Bensalem et al.PubMed ↗Publisher ↗

No numbers read from the abstract.